Mary Stenzel-Poore - Publications

Molecular Microbiology and Immunology Oregon Health and Science University, Portland, OR 

62 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Gesuete R, Stevens SL, Stenzel-Poore MP. Role of Circulating Immune Cells in Stroke and Preconditioning-Induced Protection. Acta Neurochirurgica. Supplement. 121: 39-44. PMID 26463920 DOI: 10.1007/978-3-319-18497-5_7  0.52
2015 Gesuete R, Christensen SN, Bahjat FR, Packard AE, Stevens SL, Liu M, Salazar AM, Stenzel-Poore MP. Cytosolic Receptor Melanoma Differentiation-Associated Protein 5 Mediates Preconditioning-Induced Neuroprotection Against Cerebral Ischemic Injury. Stroke; a Journal of Cerebral Circulation. PMID 26564103 DOI: 10.1161/STROKEAHA.115.010329  0.52
2015 Li S, Nie EH, Yin Y, Benowitz LI, Tung S, Vinters HV, Bahjat FR, Stenzel-Poore MP, Kawaguchi R, Coppola G, Carmichael ST. GDF10 is a signal for axonal sprouting and functional recovery after stroke. Nature Neuroscience. PMID 26502261 DOI: 10.1038/nn.4146  0.52
2015 Vartanian KB, Mitchell HD, Stevens SL, Conrad VK, McDermott JE, Stenzel-Poore MP. CpG preconditioning regulates miRNA expression that modulates genomic reprogramming associated with neuroprotection against ischemic injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 257-66. PMID 25388675 DOI: 10.1038/jcbfm.2014.193  0.52
2014 Stevens SL, Vartanian KB, Stenzel-Poore MP. Reprogramming the response to stroke by preconditioning. Stroke; a Journal of Cerebral Circulation. 45: 2527-31. PMID 24938838 DOI: 10.1161/STROKEAHA.114.002879  0.52
2014 Lanekoff I, Stevens SL, Stenzel-Poore MP, Laskin J. Matrix effects in biological mass spectrometry imaging: identification and compensation. The Analyst. 139: 3528-32. PMID 24802717 DOI: 10.1039/c4an00504j  0.52
2012 Urbanski HF, Kohama SG, West GA, Glynn C, Williams-Karnesky RL, Earl E, Neuringer MN, Renner L, Weiss A, Stenzel-Poore M, Bahjat FR. Changes in spontaneous activity assessed by accelerometry correlate with extent of cerebral ischemia-reperfusion injury in the nonhuman primate. Translational Stroke Research. 3: 442-51. PMID 23580904 DOI: 10.1007/s12975-012-0191-8  0.52
2012 McDermott JE, Jarman K, Taylor R, Lancaster M, Shankaran H, Vartanian KB, Stevens SL, Stenzel-Poore MP, Sanfilippo A. Modeling dynamic regulatory processes in stroke. Plos Computational Biology. 8: e1002722. PMID 23071432 DOI: 10.1371/journal.pcbi.1002722  0.52
2012 Gesuete R, Packard AE, Vartanian KB, Conrad VK, Stevens SL, Bahjat FR, Yang T, Stenzel-Poore MP. Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling. Journal of Neurochemistry. 123: 75-85. PMID 23050645 DOI: 10.1111/j.1471-4159.2012.07946.x  0.52
2012 Packard AE, Leung PY, Vartanian KB, Stevens SL, Bahjat FR, Stenzel-Poore MP. TLR9 bone marrow chimeric mice define a role for cerebral TNF in neuroprotection induced by CpG preconditioning. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 2193-200. PMID 23010947 DOI: 10.1038/jcbfm.2012.140  0.52
2012 McDermott JE, Vartanian KB, Mitchell H, Stevens SL, Sanfilippo A, Stenzel-Poore MP. Identification and validation of Ifit1 as an important innate immune bottleneck. Plos One. 7: e36465. PMID 22745654 DOI: 10.1371/journal.pone.0036465  0.52
2012 Leung PY, Stevens SL, Packard AE, Lessov NS, Yang T, Conrad VK, van den Dungen NN, Simon RP, Stenzel-Poore MP. Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke; a Journal of Cerebral Circulation. 43: 1383-9. PMID 22403050 DOI: 10.1161/STROKEAHA.111.641522  0.52
2012 Packard AE, Hedges JC, Bahjat FR, Stevens SL, Conlin MJ, Salazar AM, Stenzel-Poore MP. Poly-IC preconditioning protects against cerebral and renal ischemia-reperfusion injury. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 242-7. PMID 22086194 DOI: 10.1038/jcbfm.2011.160  0.52
2012 Kaur S, Li J, Stenzel-Poore MP, Ryabinin AE. Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice. Alcoholism, Clinical and Experimental Research. 36: 369-76. PMID 21895713 DOI: 10.1111/j.1530-0277.2011.01610.x  0.52
2012 Giardino WJ, Mark GP, Stenzel-Poore MP, Ryabinin AE. Dissociation of corticotropin-releasing factor receptor subtype involvement in sensitivity to locomotor effects of methamphetamine and cocaine. Psychopharmacology. 219: 1055-63. PMID 21833501 DOI: 10.1007/s00213-011-2433-y  0.52
2011 Vartanian KB, Stevens SL, Marsh BJ, Williams-Karnesky R, Lessov NS, Stenzel-Poore MP. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. Journal of Neuroinflammation. 8: 140. PMID 21999375 DOI: 10.1186/1742-2094-8-140  0.52
2011 Stevens SL, Leung PY, Vartanian KB, Gopalan B, Yang T, Simon RP, Stenzel-Poore MP. Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 8456-63. PMID 21653850 DOI: 10.1523/JNEUROSCI.0821-11.2011  0.52
2011 Pastor R, Reed C, Burkhart-Kasch S, Li N, Sharpe AL, Coste SC, Stenzel-Poore MP, Phillips TJ. Ethanol concentration-dependent effects and the role of stress on ethanol drinking in corticotropin-releasing factor type 1 and double type 1 and 2 receptor knockout mice. Psychopharmacology. 218: 169-77. PMID 21487655 DOI: 10.1007/s00213-011-2284-6  0.52
2011 Wang L, Million M, Rivier J, Rivier C, Craft N, Stenzel-Poore MP, Taché Y. CRF receptor antagonist astressin-B reverses and prevents alopecia in CRF over-expressing mice. Plos One. 6: e16377. PMID 21359208 DOI: 10.1371/journal.pone.0016377  0.52
2011 Bahjat FR, Williams-Karnesky RL, Kohama SG, West GA, Doyle KP, Spector MD, Hobbs TR, Stenzel-Poore MP. Proof of concept: pharmacological preconditioning with a Toll-like receptor agonist protects against cerebrovascular injury in a primate model of stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 1229-42. PMID 21285967 DOI: 10.1038/jcbfm.2011.6  0.52
2011 McDermott JE, Archuleta M, Stevens SL, Stenzel-Poore MP, Sanfilippo A. Defining the players in higher-order networks: predictive modeling for reverse engineering functional influence networks. Pacific Symposium On Biocomputing. Pacific Symposium On Biocomputing. 314-25. PMID 21121059  0.52
2011 Giardino WJ, Pastor R, Anacker AM, Spangler E, Cote DM, Li J, Stenzel-Poore MP, Phillips TJ, Ryabinin AE. Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine. Genes, Brain, and Behavior. 10: 78-89. PMID 20731720 DOI: 10.1111/j.1601-183X.2010.00641.x  0.52
2010 Gresack JE, Risbrough VB, Scott CN, Coste S, Stenzel-Poore M, Geyer MA, Powell SB. Isolation rearing-induced deficits in contextual fear learning do not require CRF(2) receptors. Behavioural Brain Research. 209: 80-4. PMID 20097235 DOI: 10.1016/j.bbr.2010.01.018  0.52
2009 Leung PY, Packard AE, Stenzel-Poore MP. It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection. Future Neurology. 4: 201-208. PMID 19885374 DOI: 10.2217/14796708.4.2.201  0.52
2009 Marsh B, Stevens SL, Packard AE, Gopalan B, Hunter B, Leung PY, Harrington CA, Stenzel-Poore MP. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 9839-49. PMID 19657036 DOI: 10.1523/JNEUROSCI.2496-09.2009  0.52
2009 West GA, Golshani KJ, Doyle KP, Lessov NS, Hobbs TR, Kohama SG, Pike MM, Kroenke CD, Grafe MR, Spector MD, Tobar ET, Simon RP, Stenzel-Poore MP. A new model of cortical stroke in the rhesus macaque. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 1175-86. PMID 19384334 DOI: 10.1038/jcbfm.2009.43  0.52
2009 Beckstead MJ, Gantz SC, Ford CP, Stenzel-Poore MP, Phillips PE, Mark GP, Williams JT. CRF enhancement of GIRK channel-mediated transmission in dopamine neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1926-35. PMID 19279570 DOI: 10.1038/npp.2009.25  0.52
2009 Marsh BJ, Stevens SL, Hunter B, Stenzel-Poore MP. Inflammation and the emerging role of the toll-like receptor system in acute brain ischemia. Stroke; a Journal of Cerebral Circulation. 40: S34-7. PMID 19064776 DOI: 10.1161/STROKEAHA.108.534917  0.52
2008 Pastor R, McKinnon CS, Scibelli AC, Burkhart-Kasch S, Reed C, Ryabinin AE, Coste SC, Stenzel-Poore MP, Phillips TJ. Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: a urocortin1-independent mechanism. Proceedings of the National Academy of Sciences of the United States of America. 105: 9070-5. PMID 18591672 DOI: 10.1073/pnas.0710181105  0.52
2008 Doyle KP, Yang T, Lessov NS, Ciesielski TM, Stevens SL, Simon RP, King JS, Stenzel-Poore MP. Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1235-48. PMID 18364727 DOI: 10.1038/jcbfm.2008.17  0.52
2008 Stevens SL, Ciesielski TM, Marsh BJ, Yang T, Homen DS, Boule JL, Lessov NS, Simon RP, Stenzel-Poore MP. Toll-like receptor 9: a new target of ischemic preconditioning in the brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1040-7. PMID 18183029 DOI: 10.1038/sj.jcbfm.9600606  0.52
2007 Doyle KP, Suchland KL, Ciesielski TMP, Lessov NS, Grandy DK, Scanlan TS, Stenzel-Poore MP. Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury Stroke. 38: 2569-2576. PMID 17690312 DOI: 10.1161/STROKEAHA.106.480277  0.52
2007 Rosenzweig HL, Minami M, Lessov NS, Coste SC, Stevens SL, Henshall DC, Meller R, Simon RP, Stenzel-Poore MP. Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 27: 1663-74. PMID 17327883 DOI: 10.1038/sj.jcbfm.9600464  0.52
2007 Stenzel-Poore MP, Stevens SL, King JS, Simon RP. Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis. Stroke; a Journal of Cerebral Circulation. 38: 680-5. PMID 17261715 DOI: 10.1161/01.STR.0000251444.56487.4c  0.52
2006 Stevens SL, Stenzel-Poore MP. Toll-like receptors and tolerance to ischaemic injury in the brain. Biochemical Society Transactions. 34: 1352-5. PMID 17073817 DOI: 10.1042/BST0341352  0.52
2006 Coste SC, Heard AD, Phillips TJ, Stenzel-Poore MP. Corticotropin-releasing factor receptor type 2-deficient mice display impaired coping behaviors during stress. Genes, Brain, and Behavior. 5: 131-8. PMID 16507004 DOI: 10.1111/j.1601-183X.2005.00142.x  0.52
2005 Sharpe AL, Coste SC, Burkhart-Kasch S, Li N, Stenzel-Poore MP, Phillips TJ. Mice deficient in corticotropin-releasing factor receptor type 2 exhibit normal ethanol-associated behaviors. Alcoholism, Clinical and Experimental Research. 29: 1601-9. PMID 16205360 DOI: 10.1097/01.alc.0000179371.46716.5e  0.52
2005 Meller R, Stevens SL, Minami M, Cameron JA, King S, Rosenzweig H, Doyle K, Lessov NS, Simon RP, Stenzel-Poore MP. Neuroprotection by osteopontin in stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 217-25. PMID 15678124 DOI: 10.1038/sj.jcbfm.9600022  0.52
2005 Coste SC, Murray SE, Stenzel-Poore MP. Chapter 1.3 Gene targeted animals with alterations in corticotropin pathways: new insights into allostatic control Techniques in the Behavioral and Neural Sciences. 15: 51-74. DOI: 10.1016/S0921-0709(05)80049-5  0.52
2004 Murray SE, Rosenzweig HL, Johnson M, Huising MO, Sawicki K, Stenzel-Poore MP. Overproduction of corticotropin-releasing hormone blocks germinal center formation: role of corticosterone and impaired follicular dendritic cell networks. Journal of Neuroimmunology. 156: 31-41. PMID 15465594 DOI: 10.1016/j.jneuroim.2004.06.015  0.52
2004 Stenzel-Poore MP, Stevens SL, Simon RP. Genomics of preconditioning. Stroke; a Journal of Cerebral Circulation. 35: 2683-6. PMID 15459430 DOI: 10.1161/  0.52
2004 Palmer AA, Sharpe AL, Burkhart-Kasch S, McKinnon CS, Coste SC, Stenzel-Poore MP, Phillips TJ. Corticotropin-releasing factor overexpression decreases ethanol drinking and increases sensitivity to the sedative effects of ethanol. Psychopharmacology. 176: 386-97. PMID 15138758 DOI: 10.1007/s00213-004-1896-5  0.52
2004 Hentges ST, Nishiyama M, Overstreet LS, Stenzel-Poore M, Williams JT, Low MJ. GABA release from proopiomelanocortin neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 1578-83. PMID 14973227 DOI: 10.1523/JNEUROSCI.3952-03.2004  0.52
2003 Stevens SL, Shaw TE, Dykhuizen E, Lessov NS, Hill JK, Wurst W, Stenzel-Poore MP. Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and atrocytes that express CRH-R1. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 23: 1151-9. PMID 14526225 DOI: 10.1097/01.WCB.0000086957.72078.D4  0.52
2003 Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, Chu X, Simon RP. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet (London, England). 362: 1028-37. PMID 14522533 DOI: 10.1016/S0140-6736(03)14412-1  0.52
2002 Stevens SL, Bao J, Hollis J, Lessov NS, Clark WM, Stenzel-Poore MP. The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Research. 932: 110-9. PMID 11911867 DOI: 10.1016/S0006-8993(02)02292-8  0.52
2001 Coste SC, Heldwein KA, Stevens SL, Tobar-Dupres E, Stenzel-Poore MP. IL-1alpha and TNFalpha down-regulate CRH receptor-2 mRNA expression in the mouse heart. Endocrinology. 142: 3537-45. PMID 11459800 DOI: 10.1210/endo.142.8.8342  0.52
2001 Murray SE, Lallman HR, Heard AD, Rittenberg MB, Stenzel-Poore MP. A genetic model of stress displays decreased lymphocytes and impaired antibody responses without altered susceptibility to Streptococcus pneumoniae. Journal of Immunology (Baltimore, Md. : 1950). 167: 691-8. PMID 11441072  0.52
2001 Coste SC, Murray SE, Stenzel-Poore MP. Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides. 22: 733-41. PMID 11337086 DOI: 10.1016/S0196-9781(01)00386-2  0.52
2000 Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore M, Eckenstein F. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke; a Journal of Cerebral Circulation. 31: 1715-20. PMID 10884478  0.52
2000 Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, ... ... Stenzel-Poore MP, et al. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nature Genetics. 24: 403-9. PMID 10742107 DOI: 10.1038/74255  0.52
1999 Hill JK, Gunion-Rinker L, Kulhanek D, Lessov N, Kim S, Clark WM, Dixon MP, Nishi R, Stenzel-Poore MP, Eckenstein FP. Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain Research. 820: 45-54. PMID 10023029 DOI: 10.1016/S0006-8993(98)01140-8  0.52
1997 Heldwein KA, Duncan JE, Stenzel P, Rittenberg MB, Stenzel-Poore MP. Endotoxin regulates corticotropin-releasing hormone receptor 2 in heart and skeletal muscle. Molecular and Cellular Endocrinology. 131: 167-72. PMID 9296375 DOI: 10.1016/S0303-7207(97)00103-2  0.52
1996 Martin TM, Kowalczyk C, Stevens S, Wiens GD, Stenzel-Poore MP, Rittenberg MB. Deletion in HCDR3 rescues T15 antibody mutants from a secretion defect caused by mutations in HCDR2. Journal of Immunology (Baltimore, Md. : 1950). 157: 4341-6. PMID 8906808  0.52
1996 Heinrichs SC, Stenzel-Poore MP, Gold LH, Battenberg E, Bloom FE, Koob GF, Vale WW, Pich EM. Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor. Neuroscience. 74: 303-11. PMID 8865183 DOI: 10.1016/0306-4522(96)00140-6  0.52
1996 Stenzel-Poore MP, Duncan JE, Rittenberg MB, Bakke AC, Heinrichs SC. CRH overproduction in transgenic mice: behavioral and immune system modulation. Annals of the New York Academy of Sciences. 780: 36-48. PMID 8602738 DOI: 10.1111/j.1749-6632.1996.tb15110.x  0.52
1995 Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB, Stenzel-Poore MP. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Molecular Endocrinology (Baltimore, Md.). 9: 637-45. PMID 7565810 DOI: 10.1210/mend.9.5.7565810  0.52
1994 Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2579-84. PMID 8182429  0.52
1993 Stenzel-Poore M, Vale WW, Rivier C. Relationship between antigen-induced immune stimulation and activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology. 132: 1313-8. PMID 8382598 DOI: 10.1210/endo.132.3.8382598  0.52
1992 Stenzel-Poore MP, Cameron VA, Vaughan J, Sawchenko PE, Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology. 130: 3378-86. PMID 1597149 DOI: 10.1210/endo.130.6.1597149  0.52
1992 Stenzel-Poore MP, Heldwein KA, Stenzel P, Lee S, Vale WW. Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: two members of the CRF family exist in amphibians. Molecular Endocrinology (Baltimore, Md.). 6: 1716-24. PMID 1448118 DOI: 10.1210/mend.6.10.1448118  0.52
1989 Bruderer U, Stenzel-Poore MP, Bächinger HP, Fellman JH, Rittenberg MB. Antibody combining site heterogeneity within the response to phosphocholine-keyhole limpet hemocyanin. Molecular Immunology. 26: 63-71. PMID 2467198 DOI: 10.1016/0161-5890(89)90021-7  0.52
Show low-probability matches.